Home › Overweight › North Carolina › Winston-Salem
Overweight clinical trials in Winston-Salem, NC
6 studies for Overweight are looking for participants at sites in and around Winston-Salem (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
RecruitingPhase 3
- Brookview Hills Research Associates Llc, Winston-Salem
- Wake Forest University Health Sciences, Winston-Salem
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
RecruitingPhase 3
- Wake Forest University Health Sciences, Winston-Salem
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
RecruitingPhase 3Healthy volunteers welcome
- ACCOMPLISH-2 Research Site, Winston-Salem
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
RecruitingPhase 3
- ACCOMPLISH-1 Research Site, Winston-Salem
NDPP-NextGen: A Clinical Trial to Reduce Intergenerational Obesity and Diabetes Risks
RecruitingHealthy volunteers welcome
- Wake Forest University Health Sciences, Winston-Salem
A Mobile Intervention to Reduce Pain and Improve Health-III
RecruitingPhase 2
- Wake Forest University, Winston-Salem
Overweight trials in other cities
- San Antonio, TX34 studies
- Houston, TX33 studies
- Chicago, IL29 studies
- Orlando, FL27 studies
- Miami, FL23 studies
- Las Vegas, NV23 studies
- Dallas, TX20 studies
- Atlanta, GA20 studies
- New York City, NY19 studies
- Jacksonville, FL19 studies
- Washington, DC19 studies
- Austin, TX18 studies
Other studies in Winston-Salem
- Cancer (all types)19 studies
- Acute Myeloid Leukemia18 studies
- Multiple Myeloma14 studies
- Breast Cancer14 studies
- Cardiovascular Disease14 studies
- Non-Small Cell Lung Cancer12 studies
- COPD10 studies
- Ovarian Cancer10 studies
- Type 2 Diabetes9 studies
- Myelodysplastic Syndromes9 studies
- Glioblastoma8 studies
- Chronic Lymphocytic Leukemia8 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.